Lenalidomide Plus Chemotherapy for AML

NCT01681537 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Acute Myelogenous Leukemia

Interventions

DRUG: Lenalidomide
DRUG: Mitoxantrone
DRUG: Etoposide
DRUG: Cytarabine

Sponsor

Massachusetts General Hospital